Cancer cells employ several mechanisms to evade the immune system. One major strategy involves the expression of immune checkpoint proteins such as PD-L1, which bind to receptors on T cells to inhibit their activity. Additionally, cancer cells can create an immunosuppressive microenvironment by recruiting regulatory T cells and myeloid-derived suppressor cells, which further dampen the immune response.
